Zentalis Pharmaceuticals, Inc. Accrued Income Taxes, Current
Zentalis Pharmaceuticals, Inc. (ZNTL) had Accrued Income Taxes, Current of $83.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Income Taxes, Current $83.00K.
- 2026-03-31: Accrued Income Taxes, Current $317.00K.
- 2025-12-31: Accrued Income Taxes, Current $194.00K.
- 2024-12-31: Accrued Income Taxes, Current $0.00.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2026-06-30 | $83.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $317.00K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $194.00K 10-Q · filed 2026-08-06 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-26 |
| 2024-09-30 | $152.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $425.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $403.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $281.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $654.00K 10-Q · filed 2023-11-06 |
| 2023-06-30 | $622.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $425.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $384.00K 10-K · filed 2024-02-27 |
| 2022-09-30 | $348.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $694.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $697.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $971.00K 10-K · filed 2023-03-01 |
| 2021-09-30 | $767.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $560.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $606.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $410.00K 10-K · filed 2022-02-24 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |